ANDAINTRAVENOUSSOLUTION
Approved
Oct 2017
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
2/8 — Basic
SODIUM ACETATE (sodium acetate) by Fresenius Kabi is clinical pharmacology sodium is the principal cation of extracellular fluid. First approved in 2017.
Drug data last refreshed 1w ago
Mechanism of Action
CLINICAL PHARMACOLOGY Sodium is the principal cation of extracellular fluid. It comprises more than 90% of total cations at its normal plasma concentration of approximately 140 mEq/liter. The sodium ion exerts a primary role in controlling total body water and its distribution. Acetate (CH 3 COO)…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
Worked on SODIUM ACETATE at Fresenius Kabi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.